汪贻广团队发展解析纳米药物细胞内外分布及其药效贡献的新策略.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 319
- By:
- Publication type:
- Article
Works matching IS 10031057 AND DT 2022 AND VI 31 AND IP 4
Results: 13
1
2
天然药物及仿生药物国家重点实验室2021年度学术年会顺利召开.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 317
- Publication type:
- Article
3
北京大学药剂与药理学学科连续3年居QS世界大学学科排行榜前30.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 316
- Publication type:
- Article
4
汪贻广团队在肿瘤纳米疫苗研究中取得进展.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 314
- Publication type:
- Article
5
汪贻广团队发展新一代pH超敏感纳米递送技术.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 312
- Publication type:
- Article
6
王坚成教授团队在JCR上发表综述文章: 用于RNA递送的非病毒载体.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 308
- Publication type:
- Article
7
Trends of consumption and expenditure of antibacterial traditional Chinese medicine in secondary and tertiary hospitals in China: an analysis of pharmaceutical sales data, 2011-2015.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 298, doi. 10.5246/jcps.2022.04.0275
- By:
- Publication type:
- Article
8
Clinical analysis of liver injury caused by Chinese patent medicines containing Polygonum multiflorum.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 289, doi. 10.5246/jcps.2022.04.026
- By:
- Publication type:
- Article
9
Drug-related problems among inpatients of integrated traditional Chinese and western medicine department in China.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 279, doi. 10.5246/jcps.2022.04.025
- By:
- Publication type:
- Article
10
Identification of unknown impurities in triamcinolone acetonide palmitate.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 270, doi. 10.5246/jcps.2022.04.024
- By:
- Publication type:
- Article
11
Chemical constituents from the stem of Embelia laeta.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 264, doi. 10.5246/jcps.2022.04.023
- By:
- Publication type:
- Article
12
Network pharmacology-based strategy to investigate harmacological mechanisms of Isodon serra (Maxim.) Hara for treatment of inflammatory.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 250, doi. 10.5246/jcps.2022.04.022
- By:
- Publication type:
- Article
13
2-Hydroxycircumdatin C inhibits LPS-induced BV2 cells inflammatory response via down-regulation of TLR4-mediated NF-κB/MAPK and JAK2/STAT3 pathways.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 4, p. 239, doi. 10.5246/jcps.2022.04.021
- By:
- Publication type:
- Article